1
|
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
|
Proc Natl Acad Sci U S A
|
1993
|
4.86
|
2
|
Plasma lipoproteins: apolipoprotein structure and function.
|
J Lipid Res
|
1984
|
4.12
|
3
|
Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
|
J Biol Chem
|
1978
|
3.57
|
4
|
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.
|
Science
|
1991
|
3.42
|
5
|
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.
|
J Biol Chem
|
1987
|
3.04
|
6
|
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.
|
J Biol Chem
|
1981
|
3.02
|
7
|
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.
|
Science
|
1994
|
2.98
|
8
|
Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.
|
J Biol Chem
|
1977
|
2.86
|
9
|
Expression of apolipoprotein E during nerve degeneration and regeneration.
|
Proc Natl Acad Sci U S A
|
1986
|
2.80
|
10
|
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.
|
J Clin Invest
|
1989
|
2.71
|
11
|
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
|
J Biol Chem
|
1982
|
2.71
|
12
|
Human apolipoprotein E. The complete amino acid sequence.
|
J Biol Chem
|
1982
|
2.64
|
13
|
Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.
|
J Biol Chem
|
1990
|
2.42
|
14
|
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
|
J Clin Invest
|
1980
|
2.27
|
15
|
Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.
|
J Clin Invest
|
1981
|
2.27
|
16
|
Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
|
Proc Natl Acad Sci U S A
|
1995
|
2.11
|
17
|
Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins.
|
J Biol Chem
|
1996
|
2.06
|
18
|
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.
|
J Biol Chem
|
1994
|
2.04
|
19
|
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.
|
Biochemistry
|
2000
|
2.01
|
20
|
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.
|
J Lipid Res
|
1982
|
2.01
|
21
|
Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
|
Proc Natl Acad Sci U S A
|
1982
|
1.96
|
22
|
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
|
Proc Natl Acad Sci U S A
|
1994
|
1.94
|
23
|
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.
|
Proc Natl Acad Sci U S A
|
1987
|
1.93
|
24
|
Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia.
|
Circ Res
|
1974
|
1.91
|
25
|
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
|
J Lipid Res
|
1990
|
1.90
|
26
|
Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.
|
Exp Neurol
|
1994
|
1.84
|
27
|
Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.
|
J Lipid Res
|
1980
|
1.84
|
28
|
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
|
J Biol Chem
|
1983
|
1.75
|
29
|
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.
|
Proc Natl Acad Sci U S A
|
1994
|
1.74
|
30
|
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
|
J Biol Chem
|
1988
|
1.72
|
31
|
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
|
J Biol Chem
|
1983
|
1.67
|
32
|
Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction.
|
J Biol Chem
|
1978
|
1.60
|
33
|
Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.
|
Am J Pathol
|
1977
|
1.60
|
34
|
Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.
|
Proc Natl Acad Sci U S A
|
1980
|
1.59
|
35
|
Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains.
|
J Biol Chem
|
1988
|
1.57
|
36
|
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
|
J Clin Invest
|
1994
|
1.54
|
37
|
Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex.
|
J Biol Chem
|
1978
|
1.52
|
38
|
Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E.
|
Proc Natl Acad Sci U S A
|
2001
|
1.51
|
39
|
Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding.
|
Biochemistry
|
1975
|
1.50
|
40
|
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
|
J Biol Chem
|
1986
|
1.50
|
41
|
Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residues.
|
Proc Natl Acad Sci U S A
|
1979
|
1.48
|
42
|
Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.
|
Lancet
|
1992
|
1.46
|
43
|
Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs.
|
Circ Res
|
1974
|
1.44
|
44
|
Isolation and characterization of apolipoprotein E.
|
Methods Enzymol
|
1986
|
1.39
|
45
|
Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.
|
J Clin Invest
|
1989
|
1.35
|
46
|
Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
|
J Biol Chem
|
1994
|
1.34
|
47
|
Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization.
|
J Biol Chem
|
1993
|
1.33
|
48
|
Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.
|
Biochim Biophys Acta
|
1979
|
1.33
|
49
|
Human apolipoprotein B-100 heparin-binding sites.
|
J Biol Chem
|
1987
|
1.32
|
50
|
Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles.
|
J Biol Chem
|
2001
|
1.31
|
51
|
Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.
|
J Biol Chem
|
1988
|
1.31
|
52
|
Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.
|
Proc Natl Acad Sci U S A
|
1985
|
1.25
|
53
|
Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro.
|
J Lipid Res
|
1992
|
1.25
|
54
|
The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats.
|
Atherosclerosis
|
1977
|
1.24
|
55
|
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.
|
J Biol Chem
|
1983
|
1.23
|
56
|
Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study.
|
J Neuropathol Exp Neurol
|
1994
|
1.22
|
57
|
Interaction of the N-terminal domain of apolipoprotein E4 with heparin.
|
Biochemistry
|
2001
|
1.21
|
58
|
Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
|
J Clin Invest
|
1989
|
1.20
|
59
|
Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid.
|
J Biol Chem
|
1999
|
1.19
|
60
|
New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E.
|
J Biol Chem
|
2001
|
1.17
|
61
|
Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
|
J Clin Invest
|
1983
|
1.15
|
62
|
Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
|
Protein Expr Purif
|
1999
|
1.14
|
63
|
Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice.
|
J Lipid Res
|
1997
|
1.12
|
64
|
Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.
|
J Clin Invest
|
1986
|
1.12
|
65
|
In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice.
|
J Biol Chem
|
1990
|
1.10
|
66
|
Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.
|
J Lipid Res
|
2000
|
1.09
|
67
|
Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid.
|
J Biol Chem
|
2000
|
1.09
|
68
|
Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
|
J Biol Chem
|
1984
|
1.08
|
69
|
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
|
Pharmacogenomics J
|
2006
|
1.08
|
70
|
Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia.
|
Nat Struct Biol
|
1996
|
1.07
|
71
|
Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.
|
J Clin Invest
|
1983
|
1.07
|
72
|
Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.
|
J Cell Biol
|
1988
|
1.07
|
73
|
Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey.
|
Biochemistry
|
1976
|
1.05
|
74
|
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.
|
J Clin Invest
|
1980
|
1.05
|
75
|
The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
|
J Biol Chem
|
1992
|
1.04
|
76
|
Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
|
Proc Natl Acad Sci U S A
|
1984
|
1.03
|
77
|
Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases.
|
Lancet
|
1994
|
1.02
|
78
|
Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein.
|
Biochem Biophys Res Commun
|
1978
|
1.01
|
79
|
Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor.
|
J Biol Chem
|
2000
|
1.01
|
80
|
Crosslinking of apolipoprotein E by products of lipid peroxidation.
|
J Neuropathol Exp Neurol
|
1996
|
0.99
|
81
|
Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism.
|
JAMA
|
1991
|
0.98
|
82
|
Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins.
|
Ann N Y Acad Sci
|
1980
|
0.98
|
83
|
Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.
|
J Lipid Res
|
1984
|
0.97
|
84
|
Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy.
|
Biochemistry
|
1999
|
0.97
|
85
|
Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.
|
Arteriosclerosis
|
1986
|
0.97
|
86
|
Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.
|
Structure
|
1994
|
0.96
|
87
|
Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
|
J Biol Chem
|
1998
|
0.95
|
88
|
Effects of lipid interaction on the lysine microenvironments in apolipoprotein E.
|
J Biol Chem
|
2000
|
0.93
|
89
|
Structural relationship of human apolipoprotein B48 to apolipoprotein B100.
|
J Clin Invest
|
1987
|
0.93
|
90
|
Functional domains of apolipoprotein E and apolipoprotein B.
|
Acta Med Scand Suppl
|
1987
|
0.92
|
91
|
A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
|
J Clin Invest
|
1984
|
0.92
|
92
|
Binding of an antibody mimetic of the human low density lipoprotein receptor to apolipoprotein E is governed through electrostatic forces. Studies using site-directed mutagenesis and molecular modeling.
|
J Biol Chem
|
2000
|
0.91
|
93
|
Characterization of the plasma lipoproteins and apoproteins of the Erythrocebus patas monkey.
|
Biochemistry
|
1976
|
0.91
|
94
|
An electrophoretic method for the quantitative isolation of human and swine plasma lipoproteins.
|
Biochemistry
|
1974
|
0.90
|
95
|
Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells.
|
Arteriosclerosis
|
1984
|
0.90
|
96
|
Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
|
J Lipid Res
|
1991
|
0.89
|
97
|
Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism.
|
Ann N Y Acad Sci
|
1996
|
0.88
|
98
|
Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor.
|
J Neurosci
|
1997
|
0.86
|
99
|
Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.
|
J Biol Chem
|
1989
|
0.86
|
100
|
Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease.
|
Neurosci Lett
|
1994
|
0.86
|
101
|
Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type.
|
J Biol Chem
|
1984
|
0.86
|
102
|
Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins.
|
J Lipid Res
|
1994
|
0.86
|
103
|
Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets.
|
Arteriosclerosis
|
1990
|
0.86
|
104
|
Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
|
Ann N Y Acad Sci
|
1985
|
0.85
|
105
|
Apolipoprotein E alleles in sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
|
Ann Neurol
|
1996
|
0.85
|
106
|
Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
|
Biochim Biophys Acta
|
1989
|
0.85
|
107
|
Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.
|
Protein Sci
|
2000
|
0.85
|
108
|
Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interactions.
|
Cold Spring Harb Symp Quant Biol
|
1986
|
0.84
|
109
|
Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins.
|
Exp Neurol
|
1996
|
0.84
|
110
|
Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins.
|
Biochemistry
|
1992
|
0.84
|
111
|
ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation.
|
Neurosci Lett
|
1995
|
0.84
|
112
|
Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
|
Ann Neurol
|
1996
|
0.84
|
113
|
Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.
|
J Biol Chem
|
1984
|
0.84
|
114
|
Preparative immobiline isoelectric focusing of plasma apolipoproteins on vertical slab gels.
|
Anal Biochem
|
1985
|
0.83
|
115
|
Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E.
|
Biochem Soc Trans
|
1998
|
0.83
|
116
|
The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity.
|
J Lipid Res
|
1998
|
0.82
|
117
|
Sequence-specific 1H NMR resonance assignments and secondary structure of human apolipoprotein C-I in the presence of sodium dodecyl sulfate.
|
Biochem Cell Biol
|
1998
|
0.82
|
118
|
Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli.
|
J Biol Chem
|
1997
|
0.82
|
119
|
Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE.
|
J Lipid Res
|
2001
|
0.82
|
120
|
Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome.
|
J Clin Endocrinol Metab
|
1997
|
0.82
|
121
|
Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma.
|
Metabolism
|
1984
|
0.81
|
122
|
Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.
|
Eur J Biochem
|
1984
|
0.81
|
123
|
Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology.
|
Exp Neurol
|
1995
|
0.81
|
124
|
A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder.
|
J Lipid Res
|
1993
|
0.81
|
125
|
Pigments of Elsinoe species. VI. A simple synthesis of a related perylenequinone.
|
J Chem Soc Perkin 1
|
1972
|
0.81
|
126
|
Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice.
|
Biochem Soc Trans
|
1993
|
0.80
|
127
|
Simultaneous accumulation of Evans blue dye and albumin in the canine aortic wall.
|
Am J Physiol
|
1977
|
0.79
|
128
|
Receptor interactions controlling lipoprotein metabolism.
|
Can J Biochem Cell Biol
|
1985
|
0.79
|
129
|
Characterization of apolipoprotein E-containing lipoproteins.
|
Methods Enzymol
|
1986
|
0.79
|
130
|
Structure of a monoclonal 2E8 Fab antibody fragment specific for the low-density lipoprotein-receptor binding region of apolipoprotein E refined at 1.9 A.
|
Acta Crystallogr D Biol Crystallogr
|
1999
|
0.79
|
131
|
Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma.
|
J Lipid Res
|
1993
|
0.79
|
132
|
Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
|
Neurology
|
2002
|
0.79
|
133
|
Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
|
J Lipid Res
|
1990
|
0.78
|
134
|
Protein: protein interactions in Alzheimer's disease and the CAG triplet repeat diseases.
|
Cold Spring Harb Symp Quant Biol
|
1996
|
0.78
|
135
|
Conformation of apolipoprotein E in lipoproteins.
|
J Biol Chem
|
1993
|
0.77
|
136
|
Apolipoprotein E synthesis in neurofibrosarcoma and schwannoma cell cultures from two individuals with neurofibromatosis.
|
Exp Neurol
|
1987
|
0.77
|
137
|
Expression of the human apolipoprotein E gene in cultured mammalian cells.
|
J Biol Chem
|
1986
|
0.77
|
138
|
Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.77
|
139
|
Carboxyl-terminal domain of human apolipoprotein E: expression, purification, and crystallization.
|
Protein Expr Purif
|
1999
|
0.77
|
140
|
Isolation and characterization of several plasma apolipoproteins of common marmoset monkey.
|
Arteriosclerosis
|
1990
|
0.77
|
141
|
Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.77
|
142
|
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan.
|
J Biol Chem
|
2000
|
0.76
|
143
|
Bacterial expression and purification of the Fab fragment of a monoclonal antibody specific for the low-density lipoprotein receptor-binding site of human apolipoprotein E.
|
Protein Expr Purif
|
1999
|
0.76
|
144
|
Identification of homozygosity for a human apolipoprotein A-I variant.
|
J Lipid Res
|
1986
|
0.76
|
145
|
Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant.
|
J Lipid Res
|
1994
|
0.76
|
146
|
Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.76
|
147
|
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
|
J Lipid Res
|
1995
|
0.75
|
148
|
Human apolipoprotein E7:lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins.
|
J Lipid Res
|
2000
|
0.75
|
149
|
Pathology: plasma cholesterol levels determined by lipoprotein interactions with cell surface receptors.
|
West J Med
|
1986
|
0.75
|
150
|
Mutations of apolipoprotein AI can affect cofactor function for cholesteryl ester formation by lecithin: cholesterol acyltransferase.
|
Agents Actions Suppl
|
1984
|
0.75
|
151
|
Animal carotenoids. 7. Carotenes of two colour variants of the aphid Macrosiphum liriodendri--identification of natural gamma, gamma-carotene.
|
Acta Chem Scand
|
1971
|
0.75
|
152
|
Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
|
Atherosclerosis
|
1993
|
0.75
|
153
|
Comparison of the human, canine and swine E apoproteins.
|
Biochem Biophys Res Commun
|
1980
|
0.75
|
154
|
Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100.
|
Metabolism
|
1993
|
0.75
|
155
|
Downstream regulatory elements stimulate expression of the human apolipoprotein E gene in the liver and suppress expression in the kidney of transgenic mice.
|
Trans Assoc Am Physicians
|
1990
|
0.75
|
156
|
Apolipoprotein E: receptor binding properties.
|
Adv Exp Med Biol
|
1985
|
0.75
|
157
|
Crystallization and preliminary X-ray diffraction studies on the amino-terminal (receptor-binding) domain of human apolipoprotein E3 from serum very low density lipoproteins.
|
J Mol Biol
|
1988
|
0.75
|